Skip to main content

Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?

Publication ,  Conference
Loree, JM; Bubie, A; Strickler, JH; Drusbosky, L; Kopetz, S; Raghav, KPS
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2023

Volume

41

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Loree, J. M., Bubie, A., Strickler, J. H., Drusbosky, L., Kopetz, S., & Raghav, K. P. S. (2023). Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)? In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Loree, Jonathan M., Adrian Bubie, John H. Strickler, Leylah Drusbosky, Scott Kopetz, and Kanwal Pratap Singh Raghav. “Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Loree JM, Bubie A, Strickler JH, Drusbosky L, Kopetz S, Raghav KPS. Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)? In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Loree JM, Bubie A, Strickler JH, Drusbosky L, Kopetz S, Raghav KPS. Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)? JOURNAL OF CLINICAL ONCOLOGY. 2023.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2023

Volume

41

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences